Cargando…
Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway
Alcoholic liver disease (ALD) is a worldwide health problem and hepatocyte apoptosis has been associated with the development/progression of ALD. However, no definite effective pharmacotherapy for ALD is currently available. Cilostazol, a selective type III phosphodiesterase inhibitor has been shown...
Autores principales: | Lee, Youn Ju, Shu, Mi-Sun, Kim, Jong-Yeon, Kim, Yun-Hye, Sim, Kyeong Hwa, Sung, Woo Jung, Eun, Jong Ryeol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350983/ https://www.ncbi.nlm.nih.gov/pubmed/30695051 http://dx.doi.org/10.1371/journal.pone.0211415 |
Ejemplares similares
-
Cilostazol Decreases Ethanol-Mediated TNFalpha Expression in RAW264.7 Murine Macrophage and in Liver from Binge Drinking Mice
por: Lee, Youn Ju, et al.
Publicado: (2012) -
Fucoxanthin, the constituent of Laminaria japonica, triggers AMPK-mediated cytoprotection and autophagy in hepatocytes under oxidative stress
por: Jang, Eun Jeong, et al.
Publicado: (2018) -
Cilostazol Modulates Autophagic Degradation of β-Amyloid Peptide via SIRT1-Coupled LKB1/AMPKα Signaling in Neuronal Cells
por: Park, So Youn, et al.
Publicado: (2016) -
Cilostazol induces cellular senescence and confers resistance to etoposide-induced apoptosis in articular chondrocytes
por: KIM, KANG MI, et al.
Publicado: (2012) -
Cilostazol Protects Endothelial Cells Against Lipopolysaccharide-Induced Apoptosis Through ERK1/2- and P38 MAPK-Dependent Pathways
por: Lim, Jong-Hoon, et al.
Publicado: (2009)